Your browser doesn't support javascript.
loading
Multistate Models: Accurate and Dynamic Methods to Improve Predictions of Thrombotic Risk in Patients with Cancer.
Carmona-Bayonas, Alberto; Jimenez-Fonseca, Paula; Garrido, Marcelo; Custodio, Ana; Hernandez, Raquel; Lacalle, Alejandra; Cano, Juana María; Aguado, Gema; Martínez de Castro, Eva; Alvarez Manceñido, Felipe; Macias, Ismael; Visa, Laura; Martín Richard, Marta; Mangas, Monserrat; Sánchez Cánovas, Manuel; Longo, Federico; Iglesias Rey, Leticia; Martínez Lago, Nieves; Martín Carnicero, Alfonso; Sánchez, Ana; Azkárate, Aitor; Limón, María Luisa; Hernández Pérez, Carolina; Ramchandani, Avinash; Pimentel, Paola; Cerdá, Paula; Serrano, Raquel; Gil-Negrete, Aitziber; Marín, Miguel; Hurtado, Alicia; Sánchez Bayona, Rodrigo; Gallego, Javier.
Afiliação
  • Carmona-Bayonas A; Hematology and Medical Oncology Department, Hospital General Universitario Morales Meseguer, University of Murcia, IMIB, Murcia, Spain.
  • Jimenez-Fonseca P; Medical Oncology Department, Hospital Universitario Central de Asturias, Oviedo, Spain.
  • Garrido M; Medical Oncology Department, Pontificia Universidad Católica de Chile, Santiago de Chile, Chile.
  • Custodio A; Medical Oncology Department, Hospital Universitario La Paz, Madrid, Spain.
  • Hernandez R; Medical Oncology Department, Hospital Universitario de Canarias, Tenerife, Spain.
  • Lacalle A; Medical Oncology Department, Complejo Hospitalario de Navarra, Pamplona, Spain.
  • Cano JM; Medical Oncology Department, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain.
  • Aguado G; Medical Oncology Department, Hospital Universitario Gregorio Marañon, Madrid, Spain.
  • Martínez de Castro E; Medical Oncology Department, Hospital Universitario Marqués de Valdecilla, Santander, Spain.
  • Alvarez Manceñido F; Pharmacy Department, Hospital Universitario Central de Asturias, Oviedo, Spain.
  • Macias I; Medical Oncology Department, Hospital Universitario Parc Tauli, Sabadell, Spain.
  • Visa L; Medical Oncology Department, Hospital Universitario El Mar, Barcelona, Spain.
  • Martín Richard M; Medical Oncology Department, Hospital Universitario Santa Creu i Sant Pau, Barcelona, Spain.
  • Mangas M; Medical Oncology Department, Hospital Galdakao-Usansolo, Galdakao-Usansolo, Spain.
  • Sánchez Cánovas M; Hematology and Medical Oncology Department, Hospital General Universitario Morales Meseguer, University of Murcia, IMIB, Murcia, Spain.
  • Longo F; Medical Oncology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain.
  • Iglesias Rey L; Medical Oncology Department, Complejo Hospitalario de Orense, Orense, Spain.
  • Martínez Lago N; Medical Oncology Department, Complejo Hospitalario Universitario de A Coruña, La Coruña, Spain.
  • Martín Carnicero A; Medical Oncology Department, Hospital San Pedro, Logroño, Spain.
  • Sánchez A; Medical Oncology Department, Hospital Universitario Doce de Octubre, Madrid, Spain.
  • Azkárate A; Medical Oncology Department, Hospital Universitario Son Espases, Mallorca, Spain.
  • Limón ML; Medical Oncology Department, Hospital Universitario Virgen del Rocío, Sevilla, Spain.
  • Hernández Pérez C; Medical Oncology Department, Hospital Universitario Nuestra Señora de la Candelaria, Tenerife, Spain.
  • Ramchandani A; Medical Oncology Department, Hospital Universitario Insular de Gran Canaria, Las Palmas de Gran Canaria, Spain.
  • Pimentel P; Medical Oncology Department, Hospital Santa Lucia, Cartagena, Spain.
  • Cerdá P; Medical Oncology Department, Centro Médico Teknon, Barcelona, Spain.
  • Serrano R; Medical Oncology Department, Hospital Universitario Reina Sofía, Córdoba, Spain.
  • Gil-Negrete A; Medical Oncology Department, Hospital Universitario Donostia, San Sebastián, Spain.
  • Marín M; Medical Oncology Department, Hospital Universitario Virgen de la Arrixaca, Murcia, Spain.
  • Hurtado A; Medical Oncology Department, Hospital Universitario Fundación Alcorcón, Madrid, Spain.
  • Sánchez Bayona R; Medical Oncology Department, Clínica Universidad de Navarra, Pamplona, Spain.
  • Gallego J; Medical Oncology Department, Hospital General Universitario de Elche, Elche, Spain.
Thromb Haemost ; 119(11): 1849-1859, 2019 Nov.
Article em En | MEDLINE | ID: mdl-31461750
ABSTRACT
Research into cancer-associated thrombosis (CAT) entails managing dynamic data that pose an analytical challenge. Thus, methods that assume proportional hazards to investigate prognosis entail a risk of misinterpreting or overlooking key traits or time-varying effects. We examined the AGAMENON registry, which collects data from 2,129 patients with advanced gastric cancer. An accelerated failure time (AFT) multistate model and flexible competing risks regression were used to scrutinize the time-varying effect of CAT, as well as to estimate how covariates dynamically predict cumulative incidence. The AFT model revealed that thrombosis shortened progression-free survival and overall survival with adjusted time ratios of 0.72 and 0.56, respectively. Nevertheless, its prognostic effect was nonproportional and disappeared over time if the subject managed to survive long enough. CAT that occurred later had a more pronounced prognostic effect. In the flexible competing risks model, multiple covariates were seen to have significant time-varying effects on the cumulative incidence of CAT (Khorana score, secondary thromboprophylaxis, high tumor burden, and cisplatin-containing regimen), whereas other predictors exerted a constant effect (signet ring cells and primary thromboprophylaxis). The model that assumes proportional hazards was incapable of capturing the effect of these covariates and predicted the cumulative incidence in a biased way. This study evinces that flexible and multistate models are a useful and innovative method to describe the dynamic effect of variables associated with CAT and should be more widely used.
Assuntos

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Técnicas de Apoio para a Decisão / Tromboembolia Venosa Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Thromb Haemost Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Espanha

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Técnicas de Apoio para a Decisão / Tromboembolia Venosa Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Thromb Haemost Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Espanha